Location: United States, Colorado, Aurora
Employees: 11-50
Total raised: $78M
Founded date: 2010
Investors 2
| Date | Name | Website |
| - | RA Capital... | racap.com |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 28.06.2022 | Series C | $40M | RA Capital... |
| 07.01.2020 | Series B | $35M | - |
| 20.06.2018 | Series A | $3M | - |
Mentions in press and media 10
| Date | Title | Description |
| 25.08.2023 | Rapport Therapeutics Snags $150M to Develop Precision Neurology Meds | Most available treatments for neurological disease act broadly across the brain, including in unwanted regions that cause intolerable side effects. Rapport Therapeutics — a clinical-stage biotech that was founded last year — is seeking to s... |
| 28.06.2022 | Cerebral Therapeutics Inks $40M Series C | AURORA, CO, Cerebral Therapeutics, a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today $40 million in Series C funding. >> Click here for more funding data on Cerebral Therapeutic... |
| 28.06.2022 | Cerebral Therapeutics Raises $40M in Series C Financing | Cerebral Therapeutics, an Aurora, CO-based clinical-stage pharmaceutical company, raised $40M in Series C funding. The round was led by Lynx1 Capital Management with participation from RA Capital Management, Perceptive Advisors, Vivo Capita... |
| 08.01.2020 | Aurora Pharma Company Lands $35M to Treat Drug-Resistant Epilepsy | As it develops treatments for drug-resistant epilepsy, Aurora's Cerebral Therapeutics has closed a $35 million Series B to further test its solutions. The round was led by RA Capital Management, with participation from additional new invest... |
| 07.01.2020 | Cerebral Therapeutics Raises $35M Series B | AURORA, CO, Cerebral Therapeutics, a clinical-stage pharmaceutical company developing innovative treatments for uncontrolled neurological diseases, announced today a $35 million Series B financing. >> Click here for more funding da... |
| 11.03.2019 | Term Sheet — Monday, March 11 | FOX IN THE HEN HOUSE SoftBank wants you to know that it thinks early-stage investing is important, too. Paid Content Keeping business secure in the age of digital privacy From ExtraHop SoftBank CEO Masayoshi Son has been called a “one-man b... |
| 11.03.2019 | Daily funding roundup - March 11th, 2019 | Knox raises $1.4M; Amun raised $4.2; StellaService raised $11M; HealthJoy raised $12.5M Knox: Knox is the smart and frictionless way to turn your current home into an investment property delivering passive income while empowering lifestyle ... |
| 08.03.2019 | Cerebral Therapeutics Raises Series A Extension Financing | Cerebral Therapeutics, an Aurora, Colo.-based clinical stage company, closed a $7.8m extension Series A financing. Backers included Granite Point Capital Management and Vivo Capital. This brings the total Series A investment to $11m. Led by... |
| 20.06.2018 | Term Sheet — Wednesday, June 20 | 5 Qs WITH A DEALMAKER Lux Capital partner Renata Quintini wasn’t supposed to be a venture capitalist. Paid Content Securing the enterprise without boundaries From ExtraHop “It was during a time when the Internet infrastructure was getting l... |
| 20.06.2018 | Cerebral Therapeutics Closes $3M Series A Financing | Cerebral Therapeutics, Inc., an Aurora, Colo.-based clinical-stage company focused on implanted drug-device combination therapies to improve the lives of patients with uncontrolled neurological diseases, closed a $3m Series A financing. The... |